Alas, I don't see a differentiation between local disant recurrence and spread. The senior member of the science team at Oncotype told me they tend to think the risk score covers both IF the tumor margins were adequate and clean but their legal counsel recommends against making such a statement. I think it's interesting that they also discover undiagnosed invasive cancers sometimes. The cells behave differently when tested and they've had to notify doctors to re-examine the patient and rethink recommendations for treatment. Talking to the people at Oncotype was very informative and welcome.